InsiderClue
Insiders · Profile

Reid Laurence

Director at Metagenomi Therapeutics · SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS. Filing since 21 Feb 2012. CIK 0001492749

MGX Metagenomi Therapeutics, Inc. Director · 1 trade ALNY ALNYLAM PHARMACEUTICALS, INC. SVP, Chief Business Officer · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
MGX Metagenomi Therapeutics, Inc.
9 Sep 2026
Director
Bought
20,000
$23.40K
opened
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Nov 2014
SVP, Chief Business Officer
Sold, plan not stated
10,000
$906.67K
71.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Aug 2014
SVP, Chief Business Officer
Sold, plan not stated
13,500
$909.03K
77.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 May 2014
SVP, Chief Business Officer
Sold, plan not stated
13,500
$780.68K
77.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Feb 2014
SVP, Chief Business Officer
Sold, plan not stated
20,400
$1.63M
83.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Nov 2013
SVP, Chief Business Officer
Sold, plan not stated
13,500
$720.30K
53.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 May 2013
SVP and Chief Business Officer
Sold, plan not stated
5,000
$150.00K
30.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
8 Feb 2013
SVP, Chief Business Officer
Sold, plan not stated
5,000
$125.00K
30.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
21 Feb 2012
SVP, Chief Business Officer
Bought
930
$10.00K
8.7%
9 decisions on file.